表紙
市場調查報告書

生物分解性醫療用塑膠的全球市場:2019年∼2023年

Global Biodegradable Medical Plastics Market 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 865040
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
生物分解性醫療用塑膠的全球市場:2019年∼2023年 Global Biodegradable Medical Plastics Market 2019-2023
出版日期: 2019年06月03日內容資訊: 英文 120 Pages
簡介

在醫院產生的廢棄物大部分包含醫療用塑膠,這些通常成為掩埋垃圾。醫院如果轉換使用生物分解性的拋棄式產品,會變得容易管理。塑膠使用相關的環境風險要素的意識加深,導致包含醫療的各種產業上排除塑膠的使用。英國政府最近宣布,至2042年廢止所有種類可迴避的塑膠使用的計劃。企業致力於永續可生物分解性塑膠等之類可容易分解的塑膠的替代品的開發。由於永續產品的偏好高漲,在2019年∼2023年間預測將以11%以上的年複合成長率推動全球生物分解性醫療用塑膠市場成長。

本報告提供全球生物分解性醫療用塑膠市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 報告的範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各應用領域

  • 市場區隔:各應用領域
  • 各應用領域比較:市場規模及預測(2018年∼2023年)
  • 醫療設備
  • 醫療用包裝
  • 其他
  • 市場機會:各應用領域

第7章 客戶形勢

第8章 地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲地區
  • 南美
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 創新的原料的採用
  • 生物分解性醫療用塑膠的新的用途
  • 植入用生物分解性複合材料的使用增加

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭模式

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Arkema Group
  • BASF SE
  • Corbion NV
  • Evonik Industries AG
  • Koninklijke DSM NV

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR31447

About this market

The waste generated by hospitals mostly contains medical plastics that usually end up in landfills. This could be better managed if hospitals shift their focus toward the use of biodegradable disposable products. Deepening focus on the environmental risk factors associated with the use of plastic is resulting in the elimination of plastic use across various industries, including healthcare. The UK government recently announced its plans to eliminate the use of all kinds of avoidable plastic by 2042. Enterprises are working towards developing the replacement of plastics that is sustainable and is easily degradable such as biodegradable plastics. The growing preference for sustainable products is expected to drive the growth of the global biodegradable medical plastics market size at a CAGR of more than 11% during 2019-2023.

Market Overview

Growth in geriatric population

The geriatric population is more prone to several diseases and postural control problems. The high prevalence of orthopedic disorders among the elderly population has increased the demand for medical products such as medical implants, medical devices, and others. This is expected to have a positive impact on the growth of the global biodegradable medical plastics market size.

High manufacturing cost

Compared to conventional medical plastics, the cost of manufacturing biodegradable medical plastics is high. Factors like the limited availability of bio-based renewable feedstock and higher research and development costs increase the production costs of biodegradable medical plastics. This increasing production costs will have an inflationary impact on the prices of biodegradable medical plastics.

For the detailed list of factors that will drive and challenge the growth of the biodegradable medical plastics market size during 2019-2023.

Competitive Landscape

The market appears to be fragmented with several players occupying the market share. Companies such as Arkema Group and BASF SE have intensified competition. Factors such as the increasing preference for sustainable products and the growth of the geriatric population will provide significant growth opportunities for biodegradable medical plastics manufacturers. Arkema Group, BASF SE, Corbion NV, Evonik Industries AG, and Koninklijke DSM NV are some of the major companies covered in this report.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

  • Market segmentation by application
  • Comparison by application
  • Medical devices - Market size and forecast 2018-2023
  • Medical packaging - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • MEA - Market size and forecast 2018-2023
  • South America - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Adoption of innovative raw materials
  • Emerging applications of biodegradable medical plastics
  • Rise in use of biodegradable composite materials for implants

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Arkema Group
  • BASF SE
  • Corbion NV
  • Evonik Industries AG
  • Koninklijke DSM NV

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global biomaterials market
  • Exhibit 02: Segments of global biomaterials market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Application - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by application
  • Exhibit 19: Medical devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Medical devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Medical packaging - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Medical packaging - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Market opportunity by application
  • Exhibit 26: Customer landscape
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: APAC - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: APAC - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: MEA - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: MEA - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: South America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 38: South America - Year-over-year growth 2019-2023 (%)
  • Exhibit 39: Key leading countries
  • Exhibit 40: Market opportunity
  • Exhibit 41: Impact of drivers and challenges
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Arkema Group - Vendor overview
  • Exhibit 48: Arkema Group - Business segments
  • Exhibit 49: Arkema Group - Organizational developments
  • Exhibit 50: Arkema Group - Geographic focus
  • Exhibit 51: Arkema Group - Segment focus
  • Exhibit 52: Arkema Group - Key offerings
  • Exhibit 53: BASF SE - Vendor overview
  • Exhibit 54: BASF SE - Business segments
  • Exhibit 55: BASF SE - Organizational developments
  • Exhibit 56: BASF SE - Geographic focus
  • Exhibit 57: BASF SE - Segment focus
  • Exhibit 58: BASF SE - Key offerings
  • Exhibit 59: Corbion NV - Vendor overview
  • Exhibit 60: Corbion NV - Business segments
  • Exhibit 61: Corbion NV - Organizational developments
  • Exhibit 62: Corbion NV - Geographic focus
  • Exhibit 63: Corbion NV - Segment focus
  • Exhibit 64: Corbion NV - Key offerings
  • Exhibit 65: Evonik Industries AG - Vendor overview
  • Exhibit 66: Evonik Industries AG - Business segments
  • Exhibit 67: Evonik Industries AG - Organizational developments
  • Exhibit 68: Evonik Industries AG - Geographic focus
  • Exhibit 69: Evonik Industries AG - Segment focus
  • Exhibit 70: Evonik Industries AG - Key offerings
  • Exhibit 71: Koninklijke DSM NV - Vendor overview
  • Exhibit 72: Koninklijke DSM NV - Business segments
  • Exhibit 73: Koninklijke DSM NV - Organizational developments
  • Exhibit 74: Koninklijke DSM NV - Geographic focus
  • Exhibit 75: Koninklijke DSM NV - Segment focus
  • Exhibit 76: Koninklijke DSM NV - Key offerings
  • Exhibit 77: Validation techniques employed for market sizing
  • Exhibit 78: Definition of market positioning of vendors